New Discovery Could Lead to Universal Treatment for Incurable Diseases

Key Takeaways

1. New compounds have been discovered that may lead to antiviral medications targeting multiple viruses at once.
2. The research focuses on enhancing the integrated stress response pathway in host cells to fight viral infections.
3. A unique screening method was used to evaluate nearly 400,000 chemical substances, resulting in several promising antiviral options.
4. The compounds selectively activate in cells already under viral attack, boosting the host’s natural defense mechanisms.
5. Further testing of these compounds against additional viruses is planned, with the goal of progressing to clinical trials.

A group of scientists has recently found new compounds that might pave the way for a next wave of antiviral medications that can combat multiple viruses simultaneously. Rather than focusing on a single virus, these innovative molecules activate a strong defense mechanism within the cells of the host.

Harnessing Cellular Defense

This new technology hinges on a natural system in cells known as the integrated stress response pathway. When cells sense a viral invasion, they usually activate this pathway to halt protein synthesis, which in turn prevents the virus from multiplying. The newly discovered compounds enhance this response. “When the pathway is activated during a viral attack, our compounds essentially crank it up to maximum,” states Felix Wong, the primary author.

Innovative Screening Method

To uncover these molecules, the research team utilized a unique screening method to evaluate close to 400,000 different chemical substances. This thorough examination led to several promising options. In experiments conducted on human cells, these compounds effectively assisted the cells in warding off infections from RSV, herpes, and Zika viruses. One particular compound, IBX-200, also showed success in mice, where it lowered the viral presence and alleviated symptoms associated with a herpes infection.

Selective Activation

A fascinating aspect of this strategy is that the compounds seem to only impact cells already under viral attack, activating solely when the virus triggers the stress response mechanism.

“We are truly thrilled about this research, as it allows us to utilize the stress response of host cells to create and discover broad-spectrum antiviral solutions,” mentioned James Collins, one of the co-authors of the study.

The team is now gearing up to test these compounds against additional viruses with the aim of eventually moving toward clinical testing.